Carole Seguin-Devaux - JoVE Visualize

Showing results (61-70 of 74) with videos related to

Pageof 8

Sort By:

Open Forum Infectious Diseases|November 16, 2022

Liver Disease and Treatment Needs of Asymptomatic Persons Living With Hepatitis B in SenegalAdrià Ramírez Mena, Mame Aissé Thioubou, Kalilou Diallo, et al.

Journal of the International AIDS Society|April 29, 2017

Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohortClarisse Amani-Bosse, Désiré Lucien Dahourou, Karen Malateste, et al.

ACS Infectious Diseases|February 12, 2020

(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral ActivityNicolas Humbert, Lesia Kovalenko, Francesco Saladini, et al.

The Lancet. HIV|June 7, 2020

HIV outbreaks among people who inject drugs in Europe, North America, and IsraelDon C Des Jarlais, Vana Sypsa, Jonathan Feelemyer, et al.

Viruses|January 22, 2022

The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral FailuresStephanie Popping, Valeria Cento, Carole Seguin-Devaux, et al.

BMC Medicine|April 25, 2017

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trialDésiré Lucien Dahourou, Madeleine Amorissani-Folquet, Karen Malateste, et al.

Journal of Clinical Microbiology|January 31, 2014

Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaborationLuke C Swenson, Bryan Cobb, Anna Maria Geretti, et al.

Frontiers in Microbiology|April 12, 2019

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, BelgiumLore Vinken, Katrien Fransen, Lize Cuypers, et al.

The Journal of Infectious Diseases|July 3, 2015

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE)Lucas Etienne Hermans, Valentina Svicher, Suzan Diepstraten Pas, et al.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026

Use of the Workbook Method to estimate the prevalence of chronic hepatitis B infections in the European Union and European Economic Area, 2022Ana Paula Finatto Canabarro, Erika Duffell, Disa Hansson, et al.

Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:

Pageof 8

Open Forum Infectious Diseases|November 16, 2022

Liver Disease and Treatment Needs of Asymptomatic Persons Living With Hepatitis B in SenegalAdrià Ramírez Mena, Mame Aissé Thioubou, Kalilou Diallo, et al.

Journal of the International AIDS Society|April 29, 2017

Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohortClarisse Amani-Bosse, Désiré Lucien Dahourou, Karen Malateste, et al.

ACS Infectious Diseases|February 12, 2020

(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral ActivityNicolas Humbert, Lesia Kovalenko, Francesco Saladini, et al.

The Lancet. HIV|June 7, 2020

HIV outbreaks among people who inject drugs in Europe, North America, and IsraelDon C Des Jarlais, Vana Sypsa, Jonathan Feelemyer, et al.

Viruses|January 22, 2022

The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral FailuresStephanie Popping, Valeria Cento, Carole Seguin-Devaux, et al.

BMC Medicine|April 25, 2017

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trialDésiré Lucien Dahourou, Madeleine Amorissani-Folquet, Karen Malateste, et al.

Journal of Clinical Microbiology|January 31, 2014

Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaborationLuke C Swenson, Bryan Cobb, Anna Maria Geretti, et al.

Frontiers in Microbiology|April 12, 2019

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, BelgiumLore Vinken, Katrien Fransen, Lize Cuypers, et al.

The Journal of Infectious Diseases|July 3, 2015

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE)Lucas Etienne Hermans, Valentina Svicher, Suzan Diepstraten Pas, et al.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026

Use of the Workbook Method to estimate the prevalence of chronic hepatitis B infections in the European Union and European Economic Area, 2022Ana Paula Finatto Canabarro, Erika Duffell, Disa Hansson, et al.

Pageof 8